ClinicalTrials.gg
RecruitingNCT07173088AMPUpdated Dec 2, 2025

Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture

An interventional study of Ankle Muscle Power (AMP) program and Standard of Care in Ankle Fractures, sponsored by Brian W. Noehren. Recruiting at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-12-02.

Sponsored by Brian W. Noehren · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Ankle Fractures with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Ankle Fractures · United States.

Planned enrollment
23rd of 49
60 · median 55
Started
2025
with 4 others
No phase
37 of 60
13 open now
Primary completion
2028-03
later than 17 of 19 live
Registered
59th of 60
by date

Among the 60 studies in Ankle Fractures with a site in United States, this one is the 23rd largest by planned enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2025, is one of 37 with no phase, reaches primary completion later than 17 of the 19 other live ones, and was the 59th registered.

Ankle Fractures

203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.

Browse Ankle Fractures studies →

Open to participants now

16 of the 60 studies in Ankle Fractures with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Ankle Fractures with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare two different standardized physical therapy rehabilitation programs on outcomes after an ankle fracture. Researchers will evaluate to see if the addition of ankle muscle power exercises (AMP) improve program adherence, muscle function, physical performance, and patient reported outcomes. The main questions it aims to answer are:

  1. Assess feasibility and define the initial effects of the AMP program on ankle plantar flexor rate of torque development and ankle power.

    Primary hypothesis: an ankle muscle power program will have acceptable feasibility through assessment of 80% adherence, 90% treatment fidelity, recruitment (48 participants who complete the study), 80% retention, and 80% acceptability of the AMP program to facilitate clinical translation and the ability to scale-up the treatment. In addition ankle plantar flexor muscle power, plantar flexor RTD assessed isometrically, and ankle joint power, evaluated during gait and stair ascent/descent, will have significantly greater improvements in the AMP group than the standard of care group at the end of the intervention.

  2. Test the effect of the AMP program on physical performance. Primary hypothesis: those completing the AMP program will have greater improvements in the 40 meter fast paced walk test and 11-stair climb test than those completing standard of care at the completion of the intervention.
  3. Assess the preliminary efficacy of the AMP program on patient reported outcomes and quality of life.

Primary hypothesis: compared to standard of care, the AMP program will result in improved quality of life on the ankle fracture outcome rehabilitation measure (A-FORM)

Participants will complete rehabilitation and be assessed for outcomes at baseline and after completing the intervention. Additionally exploratory outcomes will be assessed 3 months after completing the intervention.

03

Conditions studied

  • Ankle Fractures

Browse trials for

Keywords

  • Physical Therapy
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-50 years old
  • Acute orthopedic injury to the ankle requiring surgical fixation
  • Must have stable address and phone number to schedule follow up contact visits
  • English speaking
  • ≤ 35 kg/m2

Exclusion criteria

Exclusion Criteria:

  • History of chronic pain defined as pain lasting more than 3 months and bothersome at least half the days over the past 6 months that started before the fracture
  • Moderate or severe traumatic brain injury
  • Initial treatment requiring amputation
  • Spinal cord injury
  • Unable to speak or read English
  • History of schizophrenia, dementia, neurologic disorder with peripheral dysfunction, or other psychotic disorder based upon medical record or patient self-report
  • Any chronic conditions that would limit their ability to participate in an intervention
  • Multiple trauma that prevents engaging in intervention
  • Pregnant
  • Unable to participate in or complete in-person follow up visits or therapy sessions
  • In Physical Therapy at the start of the intervention.
  • Use of an assistive device to walk for community ambulation
  • Prior lower extremity fracture within the past 2 years
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Ankle Muscle Power (AMP) program + standard of care

    Participants will receive standard of care rehabilitation as needed and directed by the treating physical therapist. Participants will have additional exercises included to facilitate the development of power that will progress as participants move through the rehabilitation program. The intervention may begin approximately 12 weeks post op ± 2 weeks following fixation surgery and will have visits for up to 12 weeks with an average of 3 visits per week.

    Other: Ankle Muscle Power (AMP) program · Behavioral: Standard of Care

  • Active comparator
    Standard of care only

    Standard of care rehabilitation includes range of motion, foundational strength exercises, and other modalities (i.e., icing and or low grade NMES) as needed and directed by the treating physical therapist. The intervention may begin approximately 12 weeks post op ± 2 weeks following fixation surgery and rehabilitation will take place for up to 12 weeks with visits occurring 3 times per week on average.

    Behavioral: Standard of Care

Interventions

  • OtherAnkle Muscle Power (AMP) program

    The AMP program targets various aspects of muscle power development through a program that takes the participant through 3 different stages of training over the course of their rehabilitation. This portion of the program is in addition to receiving standard rehabilitation exercises as well.

    Also known as: Physical Therapy

  • BehavioralStandard of Care

    Standard rehabilitation program

06

What researchers measure

Primary outcomes

  1. Percentage of Participants Adhering to the Intervention

    Adherence refers to the commitment of a participant to participate in the rehab. Adherence will be measured by calculating the number of rehab sessions attended divided by the number of rehab sessions possible.

    Time frame: From baseline assessment to completion of the 10 week intervention.

  2. Percentage of Treatment That is Able to be Delivered (Fidelity)

    Fidelity refers to the ability to perform the protocol as intended and that the participants receive the intended treatment as designed. It will be calculated as the number of deviations from protocol divided by the number of treatment sessions.

    Time frame: From baseline assessment to completion of the 10 week intervention.

  3. Percentage of Participants Completing the Intervention (Retention)

    This will be calculated as the number of participants completing each intervention divided by the number of participants who start each intervention.

    Time frame: From baseline assessment to completion of the 10 week intervention.

  4. Percentage of Participants Who Find the Program Acceptable/Satisfactory

    A participant satisfaction survey will be utilized to evaluate each rehabilitation protocol, care given, and rehab facility procedures. Scores will range from 1 to 5 with 1 indicating poor performance of the facility and care received versus 5 indicating excellent performance of the facility and care received.

    Time frame: From baseline assessment to completion of the 10 week intervention.

  5. Change in Isometric Ankle Plantar Flexor Muscle Power

    Will be assessed isotonically on a dynamometer as the change in peak power from baseline to post-intervention follow-up

    Time frame: Baseline assessment and post intervention visit (10-12 weeks following baseline)

  6. Change in Ankle Rate of Torque Development (Ankle RTD)

    Will be assessed isometrically on a dynamometer as the change between baseline and post-intervention follow-up. Ankle RTD is calculated as the initial slope of the generated force curve, measured in Newton meters per second.

    Time frame: Baseline assessment and post intervention visit (10-12 weeks following baseline)

  7. Change in Ankle Joint Power During Gait

    Ankle joint power measured with 3D motion capture during walking

    Time frame: Baseline and post intervention (10-12 weeks following baseline)

  8. Change in Ankle Joint Power During Stairs (step up and down)

    Ankle joint power measured with 3D motion capture while climbing stairs

    Time frame: Baseline and post intervention (10-12 weeks following baseline)

Secondary outcomes

  1. Change in Usual Gait Speed

    Participants will walk at a pace that feels normal for the participant with the time to complete 5 meters recorded.

    Time frame: Baseline and post intervention (10-12 weeks following baseline)

  2. Change in Fastest Gait Speed

    Participants will walk at their fastest comfortable speed with the time to complete 5 meters recored.

    Time frame: Baseline and following completion of the intervention (10-12 weeks post baseline visit)

  3. Change in 11 Stair Climb Test Score

    The stair test is a measurement of functional strength, balance, and agility achieved by ascending and descending a specific number of steps (11). Scoring involves recording the total time taken to ascend and descend the steps to the nearest 100th of a second. Lower values indicate better performance.

    Time frame: Baseline visit and post intervention visit (10-12 weeks post baseline)

  4. Change in Ankle fracture outcome rehabilitation measure (A-FORM)

    The Ankle Fracture Outcome of Rehabilitation Measure (A-FORM) is a patient-reported outcome measure designed to assess recovery after an ankle fracture. It focuses on physical, social, and psychological aspects of recovery. A summary score (ranging from 0 to 100) is calculated, with lower scores indicating better outcomes.

    Time frame: Baseline and post intervention (10-12 weeks following baseline)

  5. Change in PROMIS Physical Function Computer Adaptive Test

    The PROMIS Physical Function computer adaptive test will be administered to each subject. Scale 0-100, where higher numbers indicate better physical functioning. A score of 50 is consistent with the mean score of the U.S. general population.

    Time frame: Baseline assessment and post intervention visit (10-12 weeks later)

Other outcomes

  1. Change in Brief Pain Inventory (BPI)

    This patient reported outcome measures assesses pain severity and interference. Scores range from 0-10 for each subscale of pain/severity or interference/impact with higher scores indicating greater pain severity and impact of pain. Scores can be compared to norms to determine if pain is considered significant.

    Time frame: Baseline, following the intervention (10-12 weeks post intervention), and at a 3 month follow up after completing the intervention.

  2. Change in Tampa Scale of Kinesiophobia (TSK)

    A patient reported outcome measures that assesses fear of movement due to pain. The full TSK (17-item) yields a total score between 17 and 68, where higher scores indicate greater kinesiophobia.

    Time frame: Baseline, following the intervention (10-12 weeks post intervention), and at a 3 month follow up after completing the intervention.

  3. Ankle Plantar Flexor muscle cross sectional area

    The cross sectional area of the gastrocnemius muscle will be evaluated using ultrasound imaging. The area of the muscle will be measured in cm squared.

    Time frame: Baseline and post intervention (10-12 weeks following the baseline visit)

  4. Change in the Work Productivity and Activity Impairment Questionnaire (WPAI)

    A patient reported outcome measures that assesses impairments in work productivity following an injury. The WPAI questionnaire yields four scores; absenteeism, presenteeism, overall work impairment, and activity impairment which are expressed as percentages. Absenteeism is calculated as hours missed divided by total hours available for work. Presenteeism is derived from the 0-10 scale measuring health's impact on productivity while working. Overall work impairment combines both, and activity impairment measures health's effect on non-work tasks. Higher percentage scores indicate greater impairment and reduced productivity.

    Time frame: Baseline, following the intervention (10-12 weeks post intervention) and at a 3 month follow up after completing the intervention.

  5. Change in Ankle fracture outcome rehabilitation measure (A-FORM)-midpoint

    A summary score (ranging from 0 to 100) is calculated, with lower scores indicating better outcomes. The Ankle Fracture Outcome of Rehabilitation Measure (A-FORM) is a patient-reported outcome measure designed to assess recovery after an ankle fracture. It focuses on physical, social, and psychological aspects of recovery.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  6. Change in Fastest Gait Speed-midpoint

    Participants will walk at their fastest comfortable speed with the time to complete 5 meters recorded.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  7. Change in Usual Gait Speed-midpoint

    Participants will walk at a pace that feels normal for the participant with the time to complete 5 meters recorded.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  8. Change in 11 Stair Climb Test Score-midpoint

    The stair test is a measurement of functional strength, balance, and agility achieved by ascending and descending a specific number of steps. Scoring involves recording the total time taken to ascend and descend the steps to the nearest 100th of a second. Lower values indicate better performance.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  9. Change in Isometric Ankle Plantar Flexor Muscle Power- mid point

    Will be assessed isotonically on a dynamometer as the peak power.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  10. Change in Ankle Rate of Torque Development (Ankle RTD)-midpoint

    Will be assessed isometrically on a dynamometer as the slope of the generated force curve. It is the peak rate of force development measured in Newton meters per second.

    Time frame: After completing isometric phase (16 ± 2 weeks post-op) and concentric phase (20 ± 2 weeks post-op)

  11. Change in Ankle Hindfoot Scale (AOFAS)

    The AOFAS Ankle-Hindfoot Scale is a short survey and exam that looks at ankle and foot problems. It measures three main things: pain, how well a person can move and do daily activities, and how well the ankle and foot are lined up. The score goes from 0 to 100, with higher scores meaning less pain and better function. It helps doctors and researchers track recovery and compare treatments.

    Time frame: Baseline assessment and post intervention visit (10-12 weeks following baseline)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The dissemination plan emphasizes transparency of the study, and as a study team, the investigators are committed to sharing de-identified data for external researchers.

Supporting information: Study protocol, Informed consent form

Time frame: IPD will be available at the time of manuscript acceptance and publishing. A published manuscript is planned for mid 2029.

Access criteria: Any external researcher will be able to access de-identified, non-PHI, individual participant data as part of the journal's supplementary information.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Mar 2028, 28 months after the start.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 28 months is below that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2025
First posted
Sep 15, 2025
StartActual
Nov 13, 2025
Primary completionEst.
Mar 2028
CompletionEst.
Mar 2028
Last update
Dec 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07173088
Lead sponsor
Brian W. Noehren
Responsible party
Brian W. Noehren (Associate Dean, University of Kentucky) — Sponsor-investigator
First posted
Sep 15, 2025
Start date
Nov 13, 2025
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Dec 2, 2025

Study contacts

Research Associate Senior
Contact
delong2@uky.edu
859-323-5438
Principal Investigator
Contact
b.noehren@uky.edu
859-323-1100
Principal Investigator
principal investigator · University of Kentucky

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion